This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peraino, C. Articles by Christopher, J. P. Search for Related Content PubMed PubMed Citation Articles by Peraino, C. Articles by Christopher, J. P.

Comparative Enhancing Effects of Phenobarbital, Amobarbital, Diphenylhydantoin, and Dichlorodiphenyltrichloroethane on 2-Acetylaminofluorene-induced Hepatic Tumorigenesis in the Rat¹

Division of Biological and Medical Research, Argonne National Laboratory, Argonne, Illinois 60439

Earlier studies showed that phenobarbital feeding enhanced hepatic tumorigenesis in rats previously fed 2-acetylaminofluorene for a brief period. As part of an investigation of the mechanism of this enhancement, the present study evaluated the relative enhancing abilities of amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane (DDT), agents that resemble phenobarbital to varying degrees in their effects on liver structure and metabolism. A comparison of hepatic tumor yields in rats fed 2-acetylaminofluorene, followed by the test substance (sequential treatment), showed that amobarbital and diphenylhydantoin had no enhancing activity, whereas the enhancing effect of DDT was similar to that of phenobarbital. These results show that the sequential treatment technique readily distinguishes among substances differing in enhancing ability and should prove useful in screening additional substances for this activity. The comparative biochemical effects of these substances in the liver can then be correlated with their relative enhancing abilities to provide information on the molecular events specifically associated with enhancement. Such correlations were initiated in this study by comparing the effects of the four test substances on liver weight and DNA synthesis. The results showed that the enhancers, phenobarbital and DDT, each stimulated liver DNA synthesis and increased liver weight, whereas the nonenhancers, amobarbital and diphenylhydantoin, had neither effect.

Phenobarbital and DDT both increased the early tumor incidence rate and maintained an increment in tumor incidence over that in the other treatment groups throughout the experiment, although it is not clear whether this increment would persist indefinitely. In addition, although the spectrum of tumor types observed ranged from highly differentiated to poorly differentiated in all treatment groups, DDT and phenobarbital selectively increased the incidence of highly differentiated tumors throughout most of the experiment.

¹ This work was supported by the United States Energy Research and Development Administration.

² Doctoral candidate in the General Sciences Department, Oregon State University, Corvallis, Ore. 97331.

Received 3/27/75. Accepted 7/ 9/75.

This article has been cited by other articles:

				N.J. Hodges, T.C. Orton, A.J. Strain, and J.K. Chipman Potentiation of epidermal growth factor-induced DNA synthesis in rat hepatocytes by phenobarbitone: possible involvement of oxidative stress and kinase activation Carcinogenesis, November 1, 2000; 21(11): 2041 - 2047. [Abstract] [Full Text] [PDF]

				M. Haag-Gronlund, R. Conolly, G. Scheu, L. Warngard, and R. Fransson-Steen Analysis of Rat Liver Foci Growth with a Quantitative Two-Cell Model after Treatment with 2,4,5,3',4'-Pentachlorobiphenyl Toxicol. Sci., September 1, 2000; 57(1): 32 - 42. [Abstract] [Full Text] [PDF]

				T. Shoda, K. Mitsumori, H. Onodera, K. Toyoda, C. Uneyama, K. Takada, and M. Hirose Live Tumor-Promoting Effect of {beta}-Naphthoflavone, a Strong CYP 1A1/2 Inducer, and the Relationship between CYP 1A1/2 Induction and Cx32 Decrease in Its Hepatocarcinogenesis in the Rat Toxicol Pathol, July 1, 2000; 28(4): 540 - 547. [Abstract] [PDF]

				T. Shoda, H. Onodera, M. Takeda, C. Uneyama, T. Imazawa, K. Takegawa, K. Yasuhara, T. Watanabe, M. Hirose, and K. Mitsumori Liver Tumor Promoting Effects of Fenbendazole in Rats Toxicol Pathol, September 1, 1999; 27(5): 553 - 562. [Abstract] [PDF]

				R. A. Roberts and I. Kimber Cytokines in non-genotoxic hepatocarcinogenesis Carcinogenesis, August 1, 1999; 20(8): 1397 - 1402. [Full Text] [PDF]

				S. Sanders and S. S. Thorgeirsson Phenobarbital promotes liver growth in c-myc/TGF-{alpha} transgenic mice by inducing hypertrophy and inhibiting apoptosis Carcinogenesis, January 1, 1999; 20(1): 41 - 49. [Abstract] [Full Text] [PDF]

				J. S. Sidhu and C. J. Omiecinski cAMP-associated Inhibition of Phenobarbital-inducible Cytochrome P450 Gene Expression in Primary Rat Hepatocyte Cultures J. Biol. Chem., May 26, 1995; 270(21): 12762 - 12773. [Abstract] [Full Text] [PDF]

				L. Yotti, C. Chang, and J. Trosko Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter Science, November 30, 1979; 206(4422): 1089 - 1091. [Abstract] [PDF]